Philips Enters New Agreement On Patient Monitoring Systems And Software With The Stockholm County Council

Philips enters new agreement on patient monitoring systems and software with the Stockholm County Council

Royal Philips announced that it has signed a new agreement with the Stockholm County Council on patient monitoring systems and software for the Karolinska University Hospital, which comprises the New Karolinska Solna University Hospital and the Karolinska University Hospital Huddinge.

As part of the agreement, Philips will deliver patient monitoring systems and clinical decision support applications that can be used to monitor a patient’s vital signs including the respiratory rate, pulse, blood pressure and temperature.

“The deterioration of a patient’s condition is often preceded by physiological changes that can be detected up to 24 hours before a serious event,” said Håkan Skytt, Customer Manager at Philips Sweden. “Changes in a patient’s vital signs are frequently an indication that the patient’s condition is worsening and that there is an increased risk of complications. Constant monitoring of the vital signs will allow any subtle changes to be detected and addressed in a timely manner.”

The new agreement further includes an innovation collaboration to jointly develop next-generation solutions for patient-centric care.

“For Philips, strategic partnerships with leading healthcare providers such as Karolinka University Hospital are an important and effective way to create innovative health technologies that can both streamline and enhance the delivery of care,” said Johan Folkunger, General Manager of Philips’ Health Systems businesses in Sweden.

Philips’ patient monitoring systems can measure and collect a patient’s vital signs and allow remote monitoring from a central workstation as well as bedside monitoring at an individual patient’s bedside. The data can be readily accessed and used by the relevant staff for the adequate delivery of care.

The collected data is stored centrally at the Karolinska University Hospital and can be used for the delivery of care, quality enhancement and clinical research. The New Karolinska Solna University Hospital is currently being constructed and will be admitting the first patients in the fourth quarter of 2016. The majority of the construction work is expected to be finalized in the course of 2017 and the hospital is planned to be fully operational in 2018. Karolinska University Hospital is one of the world’s leading academic hospitals, and its new site will reinforce its position in the field of highly specialized medical care.

The New Karolinska Solna University Hospital will implement a patient-centric approach to healthcare and deploy care pathways in which patient care, clinical research and training have been integrated. This is fully in line with Philips’ mission to develop meaningful innovations that make a difference for consumers, patients and healthcare providers.



GE Healthcare Named Exclusive Distributor of Veran ig4 Navigation Systems in United States

Companies join forces to provide comprehensive interventional oncology solution

Waukesha, WI - Jan 18, 2011 - GE Healthcare and Veran, a provider of proprietary 4D registration capability for precise targeting of lesions via its FDA cleared platform, today announced a strategic supplier agreement in which GE Healthcare becomes the exclusive distributor and reseller of Veran’s ig4 navigation system in the United States. The deal brings together GE Healthcare’s best-in-class Innova* imaging systems and Veran’s innovative electromagnetic navigation to create a comprehensive interventional oncology solution under a single point of contact.

Need for Interventional Oncology

The National Cancer Institute estimated more than 1.5 million new cases of cancer in the United States in 2010. Trend reports show cancer incidences are increasing in internal organs such as the thyroid, liver and kidneys. Doctors have historically treated cancer with surgery, chemotherapy, radiation, or some combination of the three. But newer image-guided minimally invasive treatments are demonstrating effectiveness, and the new specialty of interventional oncology is gaining favor. These highly specialized procedures are performed under real-time image guidance to destroy primary tumors and metastases. Some key challenges of these procedures are multimodality planning, real time guidance through complex anatomies and ability to treat selectively.

Enhanced Imaging and Navigation

The multimodality Veran ig4 system helps clinicians deliver instruments to small targets in difficult to access regions of the human body in order to diagnose and treat disease minimally invasively. The navigation system uses electromagnetic localization and 4-dimensional (x, y, z time) registration to display an interventional instrument, such as a biopsy needle, or an ablation needle, on a computer monitor with respect to anatomic imaging and treatment planning. This system is compatible with GE’s Innova imaging systems, which acquire CT-like patient images of the target organ(s) that can be exported to the navigation system in the same imaging suite, during the same interventional procedure. The resulting displayed image provides navigation information to help physicians insert biopsy needles, ablation (RF, cryotherapy, and microwave) probes and other devices through the skin more quickly and with greater target accuracy.

Also, using Innova CT images with Veran ig4 System may help to reduce the absorbed radiation dose through decreased use of fluoroscopy. “This is exciting news for our customers who want to perform complex procedures in a timely fashion with more confidence. The combined systems can help clinicians achieve greater accuracy, perform procedures more quickly and reduce radiation dose,” said Chantal Le Chat, General Manager of Interventional Radiology, GE Healthcare. “GE Healthcare and Veran share a vision for improving healthcare delivery, and this agreement is well aligned with GE’s healthymagination strategy of improving quality, access and costs for customers and their patients. Together, we offer an end-to-end interventional oncology solution that unites electromagnetic navigation capability with Innova’s image quality and dose leadership, the Innova Vision suite of advanced IR applications, and GE’s AW workstations. Our wing-to-wing solution can help the IR community solve some of the toughest problems in interventional medicine,” said Hooman Hakami, President and CEO, GE Healthcare Interventional Systems. ”Partnering with a global company such as GE Healthcare to significantly increase the access of our cutting edge 4D registration technology is a great step forward for Veran Medical,” said Jerome R. Edwards, President and CEO, Veran Medical Technologies. “GE Healthcare’s healthymagination vision is extremely synergistic with the mission that Veran Medical has by having its focus directed in the interventional oncology market.”

ABOUT GE HEALTHCARE: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, please visit

About Veran Medical Technologies, Inc.

Veran Medical Technologies is a privately held image guided medical device company focused on developing the next standard of care for minimally invasive delivery of interventional oncology therapies. Veran provides proprietary 4D registration capability for precise targeting of lesions via its FDA cleared platform. The Veran platform aims to reduce procedure time, reduce radiation exposure for the clinical staff, and increase targeting accuracy enabling physicians to cost effectively treat patients with reduced co-morbidity risk. Veran Medical Technologies is headquartered in St. Louis, MO. To learn more about Veran Medical Technologies, please visit our website at

Subscribe to this RSS feed